Physician profile
Christopher Jay Nanson
NPI 1386717882
$73,420.46
in general payments reported to CMS, 2019-2025
23 companies · $6,620 in 2025
The $6,620 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63K · 2020: $872 · 2021: $313 · 2022: $361 · 2023: $235 · 2024: $2,380 · 2025: $6,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,717 · Food and Beverage: $3,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,717.47 |
| Food and Beverage | $3,517.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nextstep Arthropedix, LLC | $60,274.28 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $5,311.28 | 2019-2025 | Persona, Rosa, Mc+ |
| Stryker Corporation | $3,866.64 | 2019-2025 | Mako, Triathlon, Insignia |
| Medacta USA, INC. | $1,520.17 | 2020-2025 | Gmk Sphere, Spherika |
| Ortho Development Corporation | $1,399.66 | 2024 | |
| Heraeus Medical, LLC. | $351.48 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $161.44 | 2019-2024 | Iovera |
| Bioventus LLC | $114.48 | 2019-2024 | Durolane, Durolane |
| Pacira Therapeutics, INC. | $73.56 | 2019-2021 | |
| Smith+Nephew, INC. | $53.09 | 2020-2025 | Renasys Touch, Pico 14, "Acticoat 4"" X 4""" |
| Fx Shoulder Solutions, INC | $43.03 | 2019 | |
| Orthalign INC | $35.00 | 2019 | |
| Ethicon US, LLC | $32.05 | 2022-2023 | Ethicon |
| Avanos Medical | $28.29 | 2023-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Baxter Healthcare | $23.01 | 2025 | Perclot |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $20.86 | 2022 | |
| Heron Therapeutics, INC. | $19.36 | 2021 | |
| Abbott Laboratories | $18.33 | 2022 | |
| Biocomposites INC | $18.33 | 2019 | |
| Si-Bone, INC. | $15.98 | 2019 | |
| Depuy Synthes Sales INC. | $13.79 | 2023 | Va-Lcp |
| Sanofi-Aventis U.S. LLC | $13.54 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Nanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.